Boards: Omega Healthcare Investors, Phreesia, Avanos Medical 

Dr. Egbuonu-Davis has broad strategic and operational experience in pharmaceuticals, public health, and consulting, including a track record of developing and implementing research, commercialization, and investment strategies for product and service innovations to enhance health and economic outcomes. Currently, Dr. Egbuonu-Davis serves as board director and on the nominating and governance committee for Phreesia (NYSE: PHR), a software-as-a-service company facilitating patient intake, payment processing, and patient engagement. She serves as board director, compliance chair, and nominating and governance committee member for Avanos Medical (NYSE: AVNS), a medical technology company with products for orthopedic pain and digestive health. She is also board director and member of compensation and nominating and governance committees for Omega Healthcare Investors (NYSE: OHI), a real estate investment trust focused on skilled nursing facilities. Additionally, she is a trustee for Johns Hopkins Medicine and provides advisory services though LED Enterprise LLC.